🔴 Day 1 Live Update
An insightful presentation by Dr. Anthony D. Baughn, PhD, on “Repurposing an Antiviral Nucleotide Analog for TB Drug Discovery.”
Dr. Baughn is an Associate Professor in the Department of Microbiology and Immunology at the University of Minnesota Medical School. His research focuses on bacterial pathogenesis and antimicrobial drug discovery, with particular work involving Mycobacterium tuberculosis and other mycobacteria.
His presentation explores the repurposing of an antiviral nucleotide analog as a potential approach in tuberculosis drug discovery. The topic reflects the broader effort to identify new therapeutic possibilities by examining existing compounds and their potential activity against bacterial pathogens.
Dr. Baughn’s research background in mycobacterial metabolism and antimicrobial drug discovery provides an important scientific perspective for this discussion. His work has contributed to research examining drug activity, bacterial metabolism, and mechanisms relevant to tuberculosis treatment.
The presentation is part of Session 1: Drug Resistance Mechanisms and Antibiotic Discovery at Frontiers in TB & Mycobacteriology 2026, bringing focused attention to ongoing research in TB drug discovery and the search for new therapeutic approaches.
This conference is organized by Impact Research Communications (IRC)
More info: https://tb.ircconferences.net/ | Frontiers in TB & Mycobacteriology
